anagrelide,bomedemstat,busulfan,hydroxyurea,ruxolitinib
novartis,imago biosciences,takeda,otsuka,incyte
['ruxolitinib', 'rux,(-crux),(-trux),(-deruxtecan)', 'img-7289', 'bomedemstat', 'anagrelide', 'busulfan', '#mpn', 'hydroxyurea', 'mpnsm']
next on bomedemstat in et (ph 2b study) #mpnsm #ash22 -dose titrated to plt ct based on dosing rules
-55% with dysgeusia
-95% of pt with plt response and no thrombotic events 
Asst Prof & Director Inpatient Leukemia Service @UChicagoMed. @NorthwesternU @Mumedicine @NU_IntMed @UCHemOncFellows alum. tweets=mine. RT?endorsement. He/him